Five Rivers RX
  • Home
  • Free Consultation
  • Clients
    • Manufacturers
    • Distributors
      • Drug, Device, and Supply Distributors
      • External Distributors
    • Logistics
    • Providers & Dispensers
  • Services
    • Business Strategy & Consulting
    • Certified Designated Representative Training Courses
    • DEA Compliance
    • FDA Reporting
    • NABP Drug Distributor Accreditation (VAWD)
    • Puerto Rico Services
    • State Compliance Services
      • Initial Assessment
      • Obtaining New Licenses
      • On-going Renewals
      • Quality & Compliance Support
  • Company
    • Leadership
    • Team
    • Careers
    • Testimonials & Accolades
  • Resources
    • Assessments
    • State Regulatory Agencies
    • Webinars
    • Courses
  • Industry Insight & Blog
  • Contact Us
    • Contact Us
    • Our Locations
Select Page

A Failure of Legislation or Rulemaking? Virtual Manufacturers & Maine

by Five Rivers Rx | Feb 4, 2021 | Drug Manufacturers, Regulations

Legislators set the rules, and regulators enforce them – and if either side doesn’t pull their weight, it leads to glaring issues which can disrupt the supply chain. A common practice for state regulators is to look to each other for support in the rulemaking process...
Drug Pricing Transparency Fight Rages On

Drug Pricing Transparency Fight Rages On

by Five Rivers Rx | May 20, 2020 | Drug Manufacturers, Industry News

Even as the COVID-19 pandemic disrupts day-to-day life, the fight over drug pricing transparency rages on between consumer groups, regulators, and industry. Regulators are assessing significant fines to increase compliance.   Fines in California & Nevada Over...
2020 Update: Continuing Pressure on Drug Manufacturers

2020 Update: Continuing Pressure on Drug Manufacturers

by Five Rivers Rx | Mar 24, 2020 | Drug Importation, Drug Manufacturers

With the developments around COVID-19, the drug manufacturers that are working on a cure for the virus have been praised as (potential) saviors across the globe. This is a stark change to how they have regarded over the last few years – drug manufacturers have...

Recent Posts

  • A Failure of Legislation or Rulemaking? Virtual Manufacturers & Maine
  • Proposed Rules for DEA Suspicious Orders
  • Industry Comments on Iowa’s Drug Distributor Accreditation Requirement
  • NavigateSOM Releases User Manual
  • Retail Pharmacy Headwinds: New Technology & Disruption

Archives

  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016

Categories

  • Competition
  • Compounding Quality Act
  • DEA
  • Drug Importation
  • Drug Manufacturers
  • Five Rivers
  • Industry News
  • NABP
  • NavigateSOM
  • Optum Rx
  • Puerto Rico
  • Regulations
  • Suspicious Order Monitoring
  • Uncategorized
  • VAWD
  • VDIP

Contact Us

 

705 Montgomery Ave., Suite 200
Penn Valley, PA 19072

E: hello@fiveriversrx.com
P: 800.962.8760

Socialize

  • Follow
  • Follow

Subscribe to Our Newsletter

Success!

Subscribe

© 2020 – Five Rivers RX – All rights reserved

     

    Subscribe to Our Newsletter